Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

ema.europa.eu

Human medicines: European public assessment reports (EPARs)

Get the latest updates from Human medicines: European public assessment reports (EPARs) directly as they happen.

Follow now 304 followers

Latest posts

Last updated 3 days ago

Human medicines European public assessment report (EPAR): Fulphila, pegfilgrastim, Date of authorisation: 20/11/2018, Revision: 14, Status: Authorised

3 days ago

Human medicines European public assessment report (EPAR): Fulphila, pegfilgrastim, Date of authorisation...

Human medicines European public assessment report (EPAR): Vafseo, vadadustat, Date of authorisation: 24/04/2023, Revision: 6, Status: Authorised

3 days ago

Human medicines European public assessment report (EPAR): Vafseo, vadadustat, Date of authorisation...

Human medicines European public assessment report (EPAR): Tuzulby, methylphenidate hydrochloride, Date of authorisation: 28/02/2025, Revision: 3, Status: Authorised

3 days ago

Human medicines European public assessment report (EPAR): Tuzulby, methylphenidate hydrochloride, Date of...

Human medicines European public assessment report (EPAR): KemSu, sufentanil,ketamine, Status: Opinion under re-examination

4 days ago

Human medicines European public assessment report (EPAR): KemSu, sufentanil,ketamine, Status: Opinion under...

Human medicines European public assessment report (EPAR): Ezmekly, mirdametinib, Date of authorisation: 17/07/2025, Revision: 3, Status: Authorised

4 days ago

Human medicines European public assessment report (EPAR): Ezmekly, mirdametinib, Date of authorisation...

Human medicines European public assessment report (EPAR): Vfend, voriconazole, Date of authorisation: 19/03/2002, Revision: 59, Status: Authorised

27 days ago

Human medicines European public assessment report (EPAR): Vfend, voriconazole, Date of authorisation...

Human medicines European public assessment report (EPAR): Cerdelga, eliglustat, Date of authorisation: 19/01/2015, Revision: 22, Status: Authorised

21 days ago

Human medicines European public assessment report (EPAR): Cerdelga, eliglustat, Date of authorisation...

Human medicines European public assessment report (EPAR): Kisqali, ribociclib, Date of authorisation: 22/08/2017, Revision: 27, Status: Authorised

12 days ago

Human medicines European public assessment report (EPAR): Kisqali, ribociclib, Date of authorisation...

Human medicines European public assessment report (EPAR): Exdensur, depemokimab, Date of authorisation: 12/02/2026, Revision: 2, Status: Authorised

4 days ago

Human medicines European public assessment report (EPAR): Exdensur, depemokimab, Date of authorisation...

Human medicines European public assessment report (EPAR): Osenvelt, denosumab, Date of authorisation: 14/02/2025, Revision: 5, Status: Authorised

4 days ago

Human medicines European public assessment report (EPAR): Osenvelt, denosumab, Date of authorisation...

Human medicines European public assessment report (EPAR): RoActemra, tocilizumab, Date of authorisation: 16/01/2009, Revision: 50, Status: Authorised

4 days ago

Human medicines European public assessment report (EPAR): RoActemra, tocilizumab, Date of authorisation...

Human medicines European public assessment report (EPAR): Lupkynis, voclosporin, Date of authorisation: 15/09/2022, Revision: 7, Status: Authorised

4 days ago

Human medicines European public assessment report (EPAR): Lupkynis, voclosporin, Date of authorisation...